We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
+7.01%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$11.7B
AUM Growth
+$679M
Cap. Flow
+$28.6M
Cap. Flow %
0.24%
Top 10 Hldgs %
14.85%
Holding
1,328
New
71
Increased
347
Reduced
587
Closed
69

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$54.8M
2
PG icon
Procter & Gamble
PG
+$48.9M
3
AMAT icon
Applied Materials
AMAT
+$39.4M
4
WBA
Walgreens Boots Alliance
WBA
+$38M
5
QCOM icon
Qualcomm
QCOM
+$36.9M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$41.2M
2
GILD icon
Gilead Sciences
GILD
+$37M
3
ABBV icon
AbbVie
ABBV
+$35.6M
4
EXC icon
Exelon
EXC
+$33.2M
5
JNJ icon
Johnson & Johnson
JNJ
+$32.6M

Sector Composition

Rank Sector Weight
1 Technology 17.91%
2 Financials 17.7%
3 Healthcare 14.21%
4 Industrials 10.49%
5 Consumer Discretionary 10.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AHL
1226
DELISTED
ASPEN Insurance Holding Limited
AHL
$34K ﹤0.01%
834
-569
-41% -$23.5K
IBOC icon
1227
International Bancshares
IBOC
$4.77B
$33K ﹤0.01%
827
-630
-43% -$25.4K
WTM icon
1228
White Mountains Insurance
WTM
$5.33B
$33K ﹤0.01%
39
-21
-35% -$18.4K
SKT icon
1229
Tanger
SKT
$4.78B
$30K ﹤0.01%
1,115
– –
VRE
1230
DELISTED
Veris Residential
VRE
$30K ﹤0.01%
1,377
– –
DYN
1231
DELISTED
Dynegy, Inc.
DYN
$30K ﹤0.01%
2,572
-13,610
-84% -$152K
FMX icon
1232
Fomento Económico Mexicano
FMX
$41.2B
$28K ﹤0.01%
301
– –
NBTB icon
1233
NBT Bancorp
NBTB
$2.82B
$27K ﹤0.01%
729
– –
LEN.B icon
1234
Lennar Class B
LEN.B
$19.9B
$25K ﹤0.01%
+507
New +$23.4K
SHPG
1235
DELISTED
Shire pic
SHPG
$23K ﹤0.01%
147
– –
ESRT icon
1236
Empire State Realty Trust
ESRT
$1B
$22K ﹤0.01%
1,063
– –
EPD icon
1237
Enterprise Products Partners
EPD
$83.7B
$21K ﹤0.01%
+800
New +$20.3K
HLIT icon
1238
Harmonic Inc
HLIT
$1.15B
$21K ﹤0.01%
4,933
-32,311
-87% -$121K
SHO icon
1239
Sunstone Hotel Investors
SHO
$2.19B
$20K ﹤0.01%
1,198
– –
LILA icon
1240
Liberty Latin America Class A
LILA
$1.72B
$17K ﹤0.01%
1,279
– –
GBT
1241
DELISTED
Global Blood Therapeutics, Inc.
GBT
$17K ﹤0.01%
+425
New +$15.9K
CRSP icon
1242
CRISPR Therapeutics
CRSP
$4.69B
$16K ﹤0.01%
+700
New +$13.3K
LPG icon
1243
Dorian LPG
LPG
$1.96B
$15K ﹤0.01%
+1,877
New +$14.4K
VXX
1244
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$12K ﹤0.01%
+430
New +$14.2K
KRYS icon
1245
Krystal Biotech
KRYS
$10.7B
$11K ﹤0.01%
+1,000
New +$10K
IBA
1246
DELISTED
Industrias Bachoco SAB De C.V.
IBA
$11K ﹤0.01%
+200
New +$11.9K
NTLA icon
1247
Intellia Therapeutics
NTLA
$1.51B
$10K ﹤0.01%
+525
New +$12.1K
FOLD
1248
DELISTED
Amicus Therapeutics
FOLD
$9K ﹤0.01%
+620
New +$8.52K
HRTX icon
1249
Heron Therapeutics
HRTX
$93.4M
$9K ﹤0.01%
+500
New +$8.15K
CYRX icon
1250
CryoPort
CYRX
$753M
$8K ﹤0.01%
+950
New +$7.45K
48 49
50
51 52

Similar funds

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking Tokyo, Japan $40.6B AUM 25.18% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

KBC Group's Q4 2017 Portfolio in Review

As of Q4 2017, KBC Group held 1,328 positions worth $11.7B, up 6.2% from $11B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

KBC Group's Q4 2017 filing shows 71 new, 347 increased, 587 reduced and 69 closed positions. Its largest new stake was Coca-Cola Europacific Partners: 311,633 shares worth $12.4M. The largest sale was Celgene Corp, an estimated $41.2M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • KBC Group's largest Q4 2017 buy was Coca-Cola Europacific Partners: 311,633 shares worth $12.4M.
  • KBC Group added most to Lam Research in Q4 2017, an estimated $54.8M increase.
  • KBC Group's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $41.2M.
  • KBC Group fully exited Gulfport Energy Corp. in Q4 2017, selling an estimated $2.72M.
  • KBC Group's ten largest holdings make up 15% of its $11.7B portfolio in Q4 2017.
  • KBC Group opened 71 new positions and closed 69 in Q4 2017.
  • KBC Group's portfolio value rose 6.2% quarter-over-quarter to $11.7B.

Based on KBC Group's 13F filing for Q4 2017, filed 7 Feb 2018.